FDA Clears Illuminate PRP System for Clinical Use

Illuminate PRP’s platelet-rich plasma (PRP) system has received FDA clearance for clinical use, the company announced.

The FDA-cleared single-spin PRP system offers a fast, efficient method for preparing high-quality PRP with high platelet capture rates, providing physicians with a reliable solution to enhance healing and improve clinical outcomes in regenerative medicine.

“Receiving FDA clearance for our PRP system is a major milestone for Illuminate PRP,” Illuminate PRP CEO Jayson Jonsson said in a press release. “This approval reflects our commitment to delivering advanced, easy-to-use technology that enables physicians to provide effective, minimally invasive treatments with optimal results.”

Illuminate PRP’s single-spin system is now available for use in clinical settings, allowing physicians to prepare PRP quickly and effectively, improving treatment efficiency and patient outcomes.

The company describes itself as “dedicated to advancing the field of regenerative medicine by providing high-quality, easy-to-use PRP systems for physicians.” With FDA clearance in hand, the company continues to expand its offerings, delivering reliable solutions to help clinicians achieve the best possible outcomes for their patients.

For more information, visit https://illuminateprp.com.